Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Intervalo de año de publicación
1.
Mem Inst Oswaldo Cruz ; 107(5): 695-7, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22850965

RESUMEN

Coxiella burnetii is the agent of Q fever , an emergent worldwide zoonosis of wide clinical spectrum. Although C. burnetii infection is typically associated with acute infection, atypical pneumonia and flu-like symptoms, endocarditis, osteoarticular manifestations and severe disease are possible, especially when the patient has a suppressed immune system; however, these severe complications are typically neglected. This study reports the sequencing of the repetitive element IS1111 of the transposase gene of C. burnetii from blood and bronchoalveolar lavage (BAL) samples from a patient with severe pneumonia following methotrexate therapy, resulting in the molecular diagnosis of Q fever in a patient who had been diagnosed with active seronegative polyarthritis two years earlier. To the best of our knowledge, this represents the first documented case of the isolation of C. burnetii DNA from a BAL sample.


Asunto(s)
Artritis/microbiología , Coxiella burnetii/genética , ADN Bacteriano/genética , Fiebre Q/diagnóstico , Secuencias Repetitivas de Ácidos Nucleicos/genética , Transposasas/genética , Enfermedad Aguda , Adulto , Lavado Broncoalveolar , Coxiella burnetii/aislamiento & purificación , Humanos , Masculino
2.
Mem. Inst. Oswaldo Cruz ; 107(5): 695-697, Aug. 2012.
Artículo en Inglés | LILACS | ID: lil-643760

RESUMEN

Coxiella burnetii is the agent of Q fever , an emergent worldwide zoonosis of wide clinical spectrum. Although C. burnetii infection is typically associated with acute infection, atypical pneumonia and flu-like symptoms, endocarditis, osteoarticular manifestations and severe disease are possible, especially when the patient has a suppressed immune system; however, these severe complications are typically neglected. This study reports the sequencing of the repetitive element IS1111 of the transposase gene of C. burnetii from blood and bronchoalveolar lavage (BAL) samples from a patient with severe pneumonia following methotrexate therapy, resulting in the molecular diagnosis of Q fever in a patient who had been diagnosed with active seronegative polyarthritis two years earlier. To the best of our knowledge, this represents the first documented case of the isolation of C. burnetii DNA from a BAL sample.


Asunto(s)
Adulto , Humanos , Masculino , Artritis/microbiología , Coxiella burnetii/genética , ADN Bacteriano/genética , Fiebre Q/diagnóstico , Secuencias Repetitivas de Ácidos Nucleicos/genética , Transposasas/genética , Enfermedad Aguda , Lavado Broncoalveolar , Coxiella burnetii/aislamiento & purificación
3.
Vet Parasitol ; 174(1-2): 119-23, 2010 Nov 24.
Artículo en Inglés | MEDLINE | ID: mdl-20810215

RESUMEN

Dirofilaria immitis carries intracellular endosymbiotic bacteria of the genus Wolbachia, known to be vital for the worms and sensitive to tetracycline antibiotics. With the purpose of studying the interaction between D. immitis and the endosymbiont Wolbachia sp., heartworm naturally infected microfilaremic or antigenemic dogs were treated with doxycycline (10mg/kg/day of the drug in three cycles of 21 days each, with 6-month intervals). Blood samples were collected on days 0, 7 and 21 of each treatment as well as on day 111 after the beginning of each cycle. A final sample was collected on day 723 from the beginning of the first treatment. The samples were examined for the presence and number of microfilariae and the presence of antigen as well as the presences of D. immitis and Wolbachia sp. DNA using PCR (polymerase chain reaction). With this approach, an evaluation of the effect of doxycycline on antigenemia and on the presence of Wolbachia sp. DNA in dogs with heartworm infection was possible. Doxycycline treatment did not alter the detection of adult parasite antigens with the exception of two animals, though the number of animals carrying Wolbachia sp. DNA decreased, despite the presence of the microfilariae. The effect of the antibiotic therapy on the worms may have interfered with the transmission of heartworm disease because the population of microfilariae and the number of microfilaremic dogs were reduced and the microfilariae positive samples that were found did not test positive for Wolbachia sp. in many cases. These findings suggest that in areas were doxycycline is extensively used D. immitis transmission may be impaired by the reduction on the number of microfilariae and on the endosymbiotic bacteria in the larvae turning them incapable of completing development once they infected a new host.


Asunto(s)
Antibacterianos/farmacología , Dirofilaria immitis/microbiología , Enfermedades de los Perros/microbiología , Enfermedades de los Perros/parasitología , Doxiciclina/farmacología , Wolbachia/efectos de los fármacos , Animales , Antígenos Bacterianos/sangre , ADN Bacteriano/sangre , Dirofilaria immitis/efectos de los fármacos , Perros , Factores de Tiempo
4.
Exp Parasitol ; 126(2): 270-2, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20457156

RESUMEN

Dirofilaria immitis is the causative agent of heartworm disease in canines and felines, and pulmonary dirofilariasis in man. It harbors a symbiotic intracellular bacterium from the genus Wolbachia that plays an important role in its biology and contributes to the inflammatory pathology of the heartworm. This endosymbiont is sensitive to the tetracycline family of antibiotics prompting its use in the treatment of filariasis. To track Wolbachia during treatment, primers were designed based on the FtsZ gene from Wolbachia. These primers amplify a single PCR product with the expected size from DNA samples derived from various species of worms that harbor Wolbachia (D. immitis, Brugia malayi and Brugia pahangy). The detection limit of Wolbachia DNA in the assay was 80 pg of D. immitis DNA. Furthermore, the primer set successfully amplified the expected PCR product using blood samples from dogs harboring the heartworm and circulating microfilariae.


Asunto(s)
ADN Bacteriano/sangre , Dirofilaria immitis/microbiología , Dirofilariasis/microbiología , Enfermedades de los Perros/microbiología , Wolbachia/genética , Animales , Proteínas Bacterianas/genética , Proteínas del Citoesqueleto/genética , ADN Bacteriano/química , Dirofilariasis/sangre , Enfermedades de los Perros/sangre , Enfermedades de los Perros/parasitología , Perros , Femenino , Masculino , Microfilarias/crecimiento & desarrollo , Microfilarias/microbiología , Reacción en Cadena de la Polimerasa/métodos , Sensibilidad y Especificidad , Simbiosis , Wolbachia/aislamiento & purificación
5.
Ciênc. rural ; 35(5): 1131-1135, set.-out. 2005.
Artículo en Portugués | LILACS | ID: lil-416188

RESUMEN

A dinâmica da infecção de B. bovis no carrapato-vetor B. microplus foi estudada em condições laboratoriais na Universidade Federal Rural do Rio de Janeiro no Laboratório de Protozoologia. Para tanto, foram examinadas 100 fêmeas ingurgitadas que se desprenderam naturalmente do hospedeiro vertebrado, sendo que 84 fêmeas apresentaram-se infectadas com esporocinetos de B. bovis, com a seguinte distribuição: 39 por cento, 33 por cento, e 12 por cento nos dias 3, 4 e 5 de incubação, respectivamente. Foram obtidas amostras de ovos provenientes das fêmeas positivas para B. bovis, 100 por cento das amostras de ovos estavam infectadas, apresentado a seguinte distribuição: 46,4 por cento, 34,5 por cento, 16,7 por cento e 2,4 por cento nos dias 4, 5, 6 e 7 de incubação, respectivamente. As freqüências acumuladas, tanto de fêmeas infectadas (84 por cento) quanto de ovos infectados (100 por cento) mantiveram-se até o 17° dia de incubação. De acordo com as freqüências acumuladas e o aumento do grau de infecção, conclui-se que amostras coletadas a partir do 5° e 7° dia de incubação, são ideais para o diagnóstico de B. bovis, em hemolinfa e ovos, respectivamente.


Asunto(s)
Animales , Babesia bovis , Infecciones/parasitología , Infecciones/veterinaria , Oviposición
6.
Int Immunopharmacol ; 5(9): 1353-64, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15953562

RESUMEN

Recent work shows that at least two cycles of antigen challenge applied in a 7-day interval are required to yield tissue eosinophil accumulation in IgE-passively sensitized rats. Since interleukin (IL)-13 is widely regarded as a key mediator in eosinophilic responses associated with mast cells and IgE, we investigated whether this cytokine could replace the first cycle of sensitization and challenge in its proeosinophilic role. We found that IL-13 (25 and 50 ng/cavity) injected into the rat pleural space led to eotaxin generation and a dose-dependent accumulation of eosinophils following IgE-passive sensitization and challenge 7 days later. IL-13 failed to cause eosinophil chemotaxis in vitro but induced eosinophil accumulation into the pleural cavity of naïve rats, which peaked 1 day and faded 72 h post-challenge. No changes were found 1 week after intrapleural injection of IL-13, except an approximately 40-50% increase in the number of adhered and non-adhered pleural mast cells. As recovered from the pleural effluent 1 week after IL-13, mast cells expressed the same amount of IgE bound on their surface as compared to controls. However, they generated 3-fold more LTC(4) following IgE-sensitization and challenge in vitro, keeping intact the amount of histamine released. Finally, pretreatment with zileuton (50 microg/cavity) 1 h before allergen challenge prevented eosinophil accumulation in those animals injected with IL-13 1 week before. In conclusion, our findings show that IL-13 causes a long-term exacerbation of the IgE-mediated eosinophilic response in a mechanism associated with heightened cysteinyl-leukotriene (cys-LT) production by resident mast cells.


Asunto(s)
Eosinofilia/inmunología , Hipersensibilidad Inmediata/inmunología , Inmunoglobulina E/inmunología , Interleucina-13/toxicidad , Animales , Movimiento Celular , Quimiocina CCL11 , Quimiocinas CC/biosíntesis , Eosinófilos/inmunología , Interleucina-13/biosíntesis , Leucotrieno C4/biosíntesis , Inhibidores de la Lipooxigenasa , Mastocitos/citología , Mastocitos/inmunología , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA